Cargando…

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China

BACKGROUND: COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the S...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi-Ru, Li, Zhi-Ju, Fu, Qi, Wang, Jin-Dong, Huang, Qing-Mei, Song, Wei-Qi, Xu, Xiao-Yu, Li, Zhi-Hao, Mao, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031186/
https://www.ncbi.nlm.nih.gov/pubmed/36949421
http://dx.doi.org/10.1186/s12889-023-15294-7
_version_ 1784910549593620480
author Zhang, Xi-Ru
Li, Zhi-Ju
Fu, Qi
Wang, Jin-Dong
Huang, Qing-Mei
Song, Wei-Qi
Xu, Xiao-Yu
Li, Zhi-Hao
Mao, Chen
author_facet Zhang, Xi-Ru
Li, Zhi-Ju
Fu, Qi
Wang, Jin-Dong
Huang, Qing-Mei
Song, Wei-Qi
Xu, Xiao-Yu
Li, Zhi-Hao
Mao, Chen
author_sort Zhang, Xi-Ru
collection PubMed
description BACKGROUND: COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness. METHODS: A cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated. RESULTS: Among 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated. CONCLUSION: Although the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15294-7.
format Online
Article
Text
id pubmed-10031186
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100311862023-03-22 The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China Zhang, Xi-Ru Li, Zhi-Ju Fu, Qi Wang, Jin-Dong Huang, Qing-Mei Song, Wei-Qi Xu, Xiao-Yu Li, Zhi-Hao Mao, Chen BMC Public Health Research BACKGROUND: COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness. METHODS: A cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated. RESULTS: Among 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated. CONCLUSION: Although the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15294-7. BioMed Central 2023-03-22 /pmc/articles/PMC10031186/ /pubmed/36949421 http://dx.doi.org/10.1186/s12889-023-15294-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Xi-Ru
Li, Zhi-Ju
Fu, Qi
Wang, Jin-Dong
Huang, Qing-Mei
Song, Wei-Qi
Xu, Xiao-Yu
Li, Zhi-Hao
Mao, Chen
The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_full The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_fullStr The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_full_unstemmed The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_short The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_sort coverage of sars-cov-2 vaccination and the willingness to receive the sars-cov-2 variant vaccine among employees in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031186/
https://www.ncbi.nlm.nih.gov/pubmed/36949421
http://dx.doi.org/10.1186/s12889-023-15294-7
work_keys_str_mv AT zhangxiru thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT lizhiju thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT fuqi thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT wangjindong thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT huangqingmei thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT songweiqi thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT xuxiaoyu thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT lizhihao thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT maochen thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT zhangxiru coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT lizhiju coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT fuqi coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT wangjindong coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT huangqingmei coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT songweiqi coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT xuxiaoyu coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT lizhihao coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT maochen coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina